Aurisco Pharmaceutical Co Ltd (SHG:605116) — Market Cap & Net Worth
Market Cap & Net Worth: Aurisco Pharmaceutical Co Ltd (605116)
Aurisco Pharmaceutical Co Ltd (SHG:605116) has a market capitalization of $1.34 Billion (CN¥9.18 Billion) as of May 4, 2026. Listed on the SHG stock exchange, this China-based company holds position #7837 globally and #1946 in its home market, demonstrating a -15.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aurisco Pharmaceutical Co Ltd's stock price CN¥22.60 by its total outstanding shares 406195234 (406.20 Million). Analyse cash flow conversion of Aurisco Pharmaceutical Co Ltd to see how efficiently the company converts income to cash.
Aurisco Pharmaceutical Co Ltd Market Cap History: 2020 to 2026
Aurisco Pharmaceutical Co Ltd's market capitalization history from 2020 to 2026. Data shows growth from $915.52 Million to $1.34 Billion (12.46% CAGR).
Aurisco Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aurisco Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.85x
Aurisco Pharmaceutical Co Ltd's market cap is 0.85 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.54x
Aurisco Pharmaceutical Co Ltd's market cap is 3.54 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $915.52 Million | $721.44 Million | $157.23 Million | 1.27x | 5.82x |
| 2021 | $1.28 Billion | $803.36 Million | $168.71 Million | 1.59x | 7.59x |
| 2022 | $1.44 Billion | $1.01 Billion | $210.90 Million | 1.43x | 6.85x |
| 2023 | $1.52 Billion | $1.26 Billion | $289.42 Million | 1.20x | 5.25x |
| 2024 | $1.26 Billion | $1.48 Billion | $354.79 Million | 0.85x | 3.54x |
Competitor Companies of 605116 by Market Capitalization
Companies near Aurisco Pharmaceutical Co Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to Aurisco Pharmaceutical Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Aurisco Pharmaceutical Co Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Aurisco Pharmaceutical Co Ltd's market cap moved from $915.52 Million to $ 1.34 Billion, with a yearly change of 12.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.34 Billion | -9.78% |
| 2025 | CN¥1.49 Billion | +18.61% |
| 2024 | CN¥1.26 Billion | -17.40% |
| 2023 | CN¥1.52 Billion | +5.21% |
| 2022 | CN¥1.44 Billion | +12.79% |
| 2021 | CN¥1.28 Billion | +39.89% |
| 2020 | CN¥915.52 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Aurisco Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.34 Billion USD |
| MoneyControl | $1.34 Billion USD |
| MarketWatch | $1.34 Billion USD |
| marketcap.company | $1.34 Billion USD |
| Reuters | $1.34 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aurisco Pharmaceutical Co Ltd
Aurisco Pharmaceutical Co.,Ltd. engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs. It also provid… Read more